EP3912624 - COMPOUNDS AND METHODS FOR TREATING ENVELOPED VIRUS INFECTIONS [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 23.11.2021 Database last updated on 03.09.2024 | |
Former | The application has been published Status updated on 22.10.2021 | Most recent event Tooltip | 23.11.2021 | Withdrawal of application | published on 08.12.2021 [2021/49] | Applicant(s) | For all designated states Virtexx 115 Rue des Hetres 69400 Arnas / FR | [2021/47] | Inventor(s) | 01 /
GARNIER, Patrice 30125 VENEZIA / IT | 02 /
SALOME, Marc 31320 MERVILLA / FR | 03 /
DANCHIN, Antoine 75003 PARIS / FR | [2021/47] | Representative(s) | Vial, Lionel, et al Bardehle Pagenberg SPE SAS SO Square Opéra 5, rue Boudreau 75009 Paris / FR | [2021/47] | Application number, filing date | 20175287.0 | 18.05.2020 | [2021/47] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3912624 | Date: | 24.11.2021 | Language: | EN | [2021/47] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 22.10.2020 | Classification | IPC: | A61K31/397, A61K31/4706, A61K31/7052, A61K31/706, A61P31/14 | [2021/47] | CPC: |
A61P31/14 (EP);
A61K31/397 (EP);
A61K31/4706 (EP);
A61K31/7052 (EP);
A61K31/706 (EP)
| C-Set: |
A61K31/397, A61K2300/00 (EP);
A61K31/4706, A61K2300/00 (EP);
A61K31/7052, A61K2300/00 (EP);
A61K31/706, A61K2300/00 (EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/47] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | VERBINDUNGEN UND VERFAHREN ZUR BEHANDLUNG VON UMHÜLLTEN VIRENINFEKTIONEN | [2021/47] | English: | COMPOUNDS AND METHODS FOR TREATING ENVELOPED VIRUS INFECTIONS | [2021/47] | French: | COMPOSÉS ET PROCÉDÉS POUR LE TRAITEMENT D'INFECTIONS DUES À DES VIRUS À ENVELOPPE | [2021/47] | Examination procedure | 29.10.2021 | Application withdrawn by applicant [2021/49] |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO2010027951 (UNIV ILLINOIS [US], et al) [X] 1,7,9,13,15 * paragraphs [0060] , [0063]; example 5; claims 4,7,8,12,18 *; | [X]GB2562691 (REHAB ALJAMAL NAYLOR [GB], et al) [X] 1,7,9,13,15 * page 6, lines 6-27 * * page 7, paragraph 1; example 1 * * page 22, lines 22-25 * * page 23, lines 13,14 *; | [X] - ALEKSANDR IANEVSKI ET AL, "Novel activities of safe-in-human broad-spectrum antiviral agents", ANTIVIRAL RESEARCH, NL, (20180601), vol. 154, doi:10.1016/j.antiviral.2018.04.016, ISSN 0166-3542, pages 174 - 182, XP055641662 [X] 1,9 * See section 3.2; page 179, column 2, paragraph 2; table 1 * DOI: http://dx.doi.org/10.1016/j.antiviral.2018.04.016 | [X] - OSUNA-RAMOS JUAN FIDEL ET AL, "Ezetimibe inhibits dengue virus infection in Huh-7 cells by blocking the cholesterol transporter Niemann-Pick C1-like 1 receptor", ANTIVIRAL RESEARCH, ELSEVIER BV, NL, (20181101), vol. 160, doi:10.1016/J.ANTIVIRAL.2018.10.024, ISSN 0166-3542, pages 151 - 164, XP085534508 [X] 1,9 * page 152, column 1, lines 2-5 * * page 157, column 1, lines 8-17 * * page 161, column 2, lines 11-16,24-30 * DOI: http://dx.doi.org/10.1016/j.antiviral.2018.10.024 | [I] - Stephen Sturley ET AL, "Insights into the COVID-19 pandemic from a rare neurodegenerative disease", doi:10.31219/osf.io/92f3s, (20200325), URL: https://osf.io/92f3s, (20201013), XP055739605 [I] 1-15 * the whole document * DOI: http://dx.doi.org/10.31219/osf.io/92f3s | [I] - MANLI WANG ET AL, "Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro", CELL RESEARCH, GB, CN, (20200204), doi:10.1038/s41422-020-0282-0, ISSN 1001-0602, XP055672526 [I] 14 * last paragraph * DOI: http://dx.doi.org/10.1038/s41422-020-0282-0 | by applicant | - FUK-WOO CHAN et al., Emerging Microbes & Infections, (20200000), vol. 9, pages 221 - 236 | - WANG et al., Cell Research, (20200000), vol. 30, pages 269 - 271 |